Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis

Abstract Increasing evidence suggests that abnormal regulation of neurotrophic factors is involved in the etiology and pathogenesis of Autism Spectrum Disorder (ASD). However, clinical data on neurotrophic factor levels in children with ASD were inconsistent. Therefore, we performed a systematic rev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shu-Han Liu, Xiao-Jie Shi, Fang-Cheng Fan, Yong Cheng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9b3a7d5a87d0466399c75efe2a144eba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9b3a7d5a87d0466399c75efe2a144eba
record_format dspace
spelling oai:doaj.org-article:9b3a7d5a87d0466399c75efe2a144eba2021-12-02T15:13:01ZPeripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis10.1038/s41598-020-79080-w2045-2322https://doaj.org/article/9b3a7d5a87d0466399c75efe2a144eba2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79080-whttps://doaj.org/toc/2045-2322Abstract Increasing evidence suggests that abnormal regulation of neurotrophic factors is involved in the etiology and pathogenesis of Autism Spectrum Disorder (ASD). However, clinical data on neurotrophic factor levels in children with ASD were inconsistent. Therefore, we performed a systematic review of peripheral blood neurotrophic factors levels in children with ASD, and quantitatively summarized the clinical data of peripheral blood neurotrophic factors in ASD children and healthy controls. A systematic search of PubMed and Web of Science identified 31 studies with 2627 ASD children and 4418 healthy controls to be included in the meta-analysis. The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges’ g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges’ g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges’ g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with ASD were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges’ g =  − 0.795; 95% CI =  − 1.723 to 0.134; P = 0.093) and neurotrophin-4 (Hedges’ g = 0.182; 95% CI =  − 0.285 to 0.650; P = 0.445) levels did not show significant differences between cases and controls. Taken together, these results clarified circulating neurotrophic factor profile in children with ASD, strengthening clinical evidence of neurotrophic factor aberrations in children with ASD.Shu-Han LiuXiao-Jie ShiFang-Cheng FanYong ChengNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shu-Han Liu
Xiao-Jie Shi
Fang-Cheng Fan
Yong Cheng
Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
description Abstract Increasing evidence suggests that abnormal regulation of neurotrophic factors is involved in the etiology and pathogenesis of Autism Spectrum Disorder (ASD). However, clinical data on neurotrophic factor levels in children with ASD were inconsistent. Therefore, we performed a systematic review of peripheral blood neurotrophic factors levels in children with ASD, and quantitatively summarized the clinical data of peripheral blood neurotrophic factors in ASD children and healthy controls. A systematic search of PubMed and Web of Science identified 31 studies with 2627 ASD children and 4418 healthy controls to be included in the meta-analysis. The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges’ g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges’ g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges’ g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with ASD were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges’ g =  − 0.795; 95% CI =  − 1.723 to 0.134; P = 0.093) and neurotrophin-4 (Hedges’ g = 0.182; 95% CI =  − 0.285 to 0.650; P = 0.445) levels did not show significant differences between cases and controls. Taken together, these results clarified circulating neurotrophic factor profile in children with ASD, strengthening clinical evidence of neurotrophic factor aberrations in children with ASD.
format article
author Shu-Han Liu
Xiao-Jie Shi
Fang-Cheng Fan
Yong Cheng
author_facet Shu-Han Liu
Xiao-Jie Shi
Fang-Cheng Fan
Yong Cheng
author_sort Shu-Han Liu
title Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
title_short Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
title_full Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
title_fullStr Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
title_full_unstemmed Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
title_sort peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9b3a7d5a87d0466399c75efe2a144eba
work_keys_str_mv AT shuhanliu peripheralbloodneurotrophicfactorlevelsinchildrenwithautismspectrumdisorderametaanalysis
AT xiaojieshi peripheralbloodneurotrophicfactorlevelsinchildrenwithautismspectrumdisorderametaanalysis
AT fangchengfan peripheralbloodneurotrophicfactorlevelsinchildrenwithautismspectrumdisorderametaanalysis
AT yongcheng peripheralbloodneurotrophicfactorlevelsinchildrenwithautismspectrumdisorderametaanalysis
_version_ 1718387646978326528